1-5 of 5
Rubina Siddiqi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Disease Burden, CAR-T Expansion, and Mononuclear Cell Recovery on Overall Response and Duration of Response in Zuma-3 Pivotal Study

Sabina Adhikary, Colleen Schweitzer, Fang Sun, Daqin Mao, Sharon Mu, Srikanth Mannem, Rubina Siddiqi, Tsveta Hadjivassileva, Rita Damico Khalid, Rhine Shen
Journal: Blood
Blood (2024) 144 (Supplement 1): 4193.
https://doi.org/10.1182/blood-2024-208999
Published: 2024
Journal Articles

Real-World (RW) Outcomes for Brexucabtagene Autoleucel (Brexu-Cel) Treatment in Patients (Pts) with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) By High-Risk Features and Prior Treatments: Updated Evidence from the CIBMTR® Registry

Kitsada Wudhikarn, Evandro Bezerra, Yang Yang, Miguel-Angel Perales, Nitin Jain, Usama Gergis, Ahmed Aribi, LaQuisa Hill, Jessica T. Leonard, Forat Lutfi, Soyoung Kim, Matthew Bye, Zhen-Huan Hu, Hai-Lin Wang, Zhong-Cheng Luo, Rubina Siddiqi, Rita Damico Khalid, Jessica Speiser, Marcelo C. Pasquini, Partow Kebriaei, Lori Muffly
Journal: Blood
Blood (2024) 144 (Supplement 1): 5092.
https://doi.org/10.1182/blood-2024-198455
Published: 2024
Journal Articles

A Propensity Score-Matched Analysis on the Outcomes of Brexucabtagene Autoleucel from Zuma-2 Study and Allogeneic Stem Cell Transplantation from the EBMT Database in Relapsed and Refractory Post-Btki Mantle Cell Lymphoma

Nora Liebers, Hervé Finel, Dominic Edelmann, Guido Kobbe, Ben-Niklas Bärmann, Yasmina Serroukh, Didier Blaise, Dietrich W. Beelen, Carlos Solano, Maija Itäla-remes, Annoek E.C. Broers, Goda Choi, Nicolaus Kroeger, Jenny Louise Byrne, Jean-Jacques Tudesq, Ana Nunes, Rubina Siddiqi, Elande Baro, Dan Zheng, Ioana Kloos, Peter Dreger, Anna Maria Sureda Balari, Bertram Glass, Sascha Dietrich
Journal: Blood
Blood (2023) 142 (Supplement 1): 3494.
https://doi.org/10.1182/blood-2023-174368
Published: 2023
Journal Articles

A Comparison of Overall Survival with Brexucabtagene Autoleucel (Brexu-cel) CAR T-Cell Therapy (ZUMA-2) and Standard of Care (SCHOLAR-2) in Patients with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor (BTKi)

Georg Hess, Martin Dreyling, Lucie Oberic, Eva Gine, Pier Luigi Zinzani, Kim M. Linton, Adam Vilmar, Mats Jerkeman, Jenny MH Chen, Anke Ohler, Stephan Stilgenbauer, Catherine Thieblemont, Jonathan Lambert, Vittorio Ruggero Zilioli, Juan-Manuel Sancho, Ana Jimenez-Ubieto, Luca Fischer, Toby A. Eyre, Sam Keeping, Julie E Park, James J Wu, Rubina Siddiqi, John Reitan, Gab Castaigne, Gilles Salles
Journal: Blood
Blood (2022) 140 (Supplement 1): 10296–10299.
https://doi.org/10.1182/blood-2022-162638
Published: 2022
Journal Articles

Assessment of Durable Responses after Brexucabtagene Autoleucel (KTE-X19) in the ZUMA-2 Study in Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL)

Javier Munoz, Patrick M. Reagan, Andre H. Goy, David B. Miklos, Dan Zheng, Xiang Fang, Rhine R. Shen, Rubina Siddiqi, Ioana Kloos, Marie José Kersten, Michael Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9320–9322.
https://doi.org/10.1182/blood-2022-158097
Published: 2022